Septic serum induces glucocorticoid resistance and modifies the expression of glucocorticoid isoforms receptors: a prospective cohort study and in vitro experimental assay
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Background: A protective role for glucocorticoid therapy in animal models of sepsis was shown many decades ago. In human sepsis, there is new interest in glucocorticoid therapy at a physiological dose after reports of improved response to vasopressor drugs and decreased mortality in a selected group of patients. However, other reports have not confirmed these results. Cellular glucocorticoid resistance could explain a possible cause of that. To evaluate this hypothesis, we evaluated the expression of glucocorticoid receptor beta, the dominant negative isoform of glucocorticoid receptor, in peripheral mononuclear cells of septic patients and the effect of serum septic patients over glucocorticoid receptor expression and glucocorticoid sensitivity in immune cells culture. Methods: A prospective cohort study and an in vitro experimental study with matched controls were developed. Nine patients with septic shock and nine healthy controls were prospectively enrolled. Mononuclear cells and serum samples were obtained from the patients with sepsis on admission to the Intensive Care Unit and on the day of discharge from hospital, and from healthy volunteers matched by age and sex with the patients. Glucocorticoid receptor alpha and beta expression from patients and from immune cell lines cultured in the presence of serum from septic patients were studied by western blot. Glucocorticoid sensitivity was studied in control mononuclear cells cultured in the presence of serum from normal or septic patients. A statistical analysis was performed using a Mann-Whitney test for non-parametric data and analysis of variance for multiple comparison; P < 0.05 was considered significant. Results: The patients' glucocorticoid receptor beta expression was significantly higher on admission than on discharge, whereas the alpha receptor was not significantly different. In vitro, septic serum induced increased expression of both receptors in T and B cells in culture, with a greater effect on receptor beta than the control serum. Septic serum induced glucocorticoid resistance in control mononuclear cells. Conclusion: There is a transient increased expression of glucocorticoid receptor beta in mononuclear cells from septic patients. Serum from septic patients induces cell glucocorticoid resistance in vitro. Our findings support a possible cell glucocorticoid resistance in sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clinical studies in patients with septic shock [79,80] and ARDS [7] have provided evidence of an association between the degree of intracellular glucocorticoid resistance, disease severity, and mortality.”
From Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a multispecialty task force of the society of critical care medicine (SCCM) and the European society of intensive care medicine (ESICM) (2017) · cites this paper as [80]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Sepsis is also characterized by an increased expression of the GR isoform GR-β in circulating cells, resulting in an imbalance between GRα and GRβ [80,83].”
In the citing paper
“and increased GR-β (dominant negative activity on GR-induced transcription) [80,83,84].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503 · cited 2×
“Sepsis is a leading cause of death in intensive care units (ICUs) around the world [1].”
BackgroundDellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869 · cited 1×
“The actions of GCs are mediated by their receptor (GR), which acts as a ligand-dependent transcription factor [29-31].”
BackgroundBone, R. C., Fisher, C. J., Clemmer, T. P., Slotman, G. J., Metz, C. A., Balk, R. A., & The Methylprednisolone Severe Sepsis Study Group (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171101 · Cited by 1,440 · cited 1×
“The early approach of high dose GCs for sepsis therapy was abandoned when the potential benefits initially reported [9-11] could not be replicated, and higher mortality associated with secondary infections was suggested [12,13].”
BackgroundDombrovskiy, V. Y., Martin, A. A., Sunderram, J., & Paz, H. L. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000261890.41311.e9 · Cited by 1,249
Annane, D. (2000) · JAMA · doi:10.1001/jama.283.8.1038 · Cited by 1,000 · cited 2×
“A renewed interest in GC therapy in sepsis, at what has been termed a physiological dose, was seen after reports of improved response to vasopressor drugs and decreased mortality in selected groups of patients who had an inadequate response to adrenocorticotropin hormone (ACTH) (defined as an increase in total plasma…”
BackgroundMarik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
Sprung, C. L., Caralis, P. V., Marcial, E. H., Pierce, M., Gelbard, M. A., Long, W. M., Duncan, R. C., Tendler, M. D., & Karpf, M. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411013111801 · Cited by 765 · cited 1×
“The early approach of high dose GCs for sepsis therapy was abandoned when the potential benefits initially reported [9-11] could not be replicated, and higher mortality associated with secondary infections was suggested [12,13].”
BackgroundMeasurements of Serum Free Cortisol in Critically Ill Patients
Hamrahian, A. H., Oseni, T. S., & Arafah, B. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa020266 · Cited by 726 · cited 1×
“This selection method and its role as a prognostic factor has also been challenged [20-25].”
MethodGlucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117943 · Cited by 642 · cited 2×
“The most studied are GR alpha (GRa), the classical receptor that mediates GC actions, and GR beta (GRb), which can act as a dominant negative [34-37].”
BackgroundCorticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
Cronin, L., Cook, D. J., Carlet, J., Heyland, D. K., King, D. B. M., Lansang, M. A. D., & Fisher, Jr. (1995) · Critical Care Medicine · doi:10.1097/00003246-199508000-00019 · Cited by 622 · cited 1×
“The early approach of high dose GCs for sepsis therapy was abandoned when the potential benefits initially reported [9-11] could not be replicated, and higher mortality associated with secondary infections was suggested [12,13].”
BackgroundCorticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults: A Systematic Review
Annane, D., Bellissant, E., Bollaert, P.-E., Briegel, J., Confalonieri, M., De Gaudio, R., Keh, D., Kupfer, Y., Oppert, M., & Meduri, G. U. (2009) · JAMA · doi:10.1001/jama.2009.815 · Cited by 561 · cited 1×
“The role of GC therapy in septic patients is still controversial [19,53-55].”
BackgroundSteroids in the Treatment of Clinical Septic Shock
SCHUMER, W. (1976) · Annals of Surgery · doi:10.1097/00000658-197609000-00011 · Cited by 545
Steroid controversy in sepsis and septic shock: A meta-analysis
Lefering, R., & Neugebauer, E. A. M. (1995) · Critical Care Medicine · doi:10.1097/00003246-199507000-00021 · Cited by 485 · cited 1×
“The early approach of high dose GCs for sepsis therapy was abandoned when the potential benefits initially reported [9-11] could not be replicated, and higher mortality associated with secondary infections was suggested [12,13].”
BackgroundWebster, J. C., Oakley, R. H., Jewell, C. M., & Cidlowski, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121455098 · Cited by 482 · cited 1×
“The role of GC therapy in septic patients is still controversial [19,53-55].”
BackgroundThe Dominant Negative Activity of the Human Glucocorticoid Receptor β Isoform
Oakley, R. H., Jewell, C. M., Yudt, M. R., Bofetiado, D. M., & Cidlowski, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27857 · Cited by 453 · cited 1×
“The most studied are GR alpha (GRa), the classical receptor that mediates GC actions, and GR beta (GRb), which can act as a dominant negative [34-37].”
BackgroundEffectiveness of treatments for severe sepsis: A prospective, multicenter, observational study.
Ferrer, R., Artigas, A., Suarez, D., Palencia, E., Levy, M. M., Arenzana, A., Pérez, X. L., & Sirvent, J.-M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1912oc · Cited by 433
Molecular mechanisms of glucocorticoid action and resistance
Schaaf, M. J. M., & Cidlowski, J. A. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00263-7 · Cited by 416 · cited 2×
“Insufficient adrenal GC secretion and peripheral GC resistance are factors likely to influence the response of patients to corticosteroids [26-28].”
BackgroundThe genomic structure of the human glucocorticoid receptor.
Encío, I. J., & Detera-Wadleigh, S. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89627-6 · Cited by 392
The human glucocorticoid receptor: One gene, multiple proteins and diverse responses
ZHOU, J., & CIDLOWSKI, J. (2005) · Steroids · doi:10.1016/j.steroids.2005.02.006 · Cited by 372 · cited 1×
“Although the GR is the product of a single gene, several isoforms have been described [32,33].”
BackgroundCardiovascular management of septic shock
Dellinger, R. P. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000057403.73299.a6 · Cited by 369 · cited 1×
“In spite of new developments in critical care and sepsis therapy, the mortality rates associated with severe sepsis and septic shock are still over 30% in most reports [1-5].”
BackgroundDiagnosis of Adrenal Insufficiency in Severe Sepsis and Septic Shock
Annane, D., Maxime, V., Ibrahim, F., Alvarez, J. C., Abe, E., & Boudou, P. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1369oc · Cited by 327 · cited 1×
“This selection method and its role as a prognostic factor has also been challenged [20-25].”
MethodSeptic Shock and Sepsis: A Comparison of Total and Free Plasma Cortisol Levels
Ho, J. T., Al-Musalhi, H., Chapman, M. J., Quach, T., Thomas, P. D., Bagley, C. J., Lewis, J. G., & Torpy, D. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0265 · Cited by 312 · cited 1×
“This selection method and its role as a prognostic factor has also been challenged [20-25].”
MethodThe Glucocorticoid Receptor: Coding a Diversity of Proteins and Responses through a Single Gene
Yudt, M. R., & Cidlowski, J. A. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0106 · Cited by 275 · cited 1×
“Although the GR is the product of a single gene, several isoforms have been described [32,33].”
BackgroundSousa, A. R., Lane, S. J., Cidlowski, J. A., Staynov, D. Z., & Lee, T. H. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.106486 · Cited by 274 · cited 2×
“A change in the expression of the GR isoforms with greater GRb expression has been proposed as a mechanism of GC resistance in chronic inflammatory conditions such as rheumatoid arthritis, ulcerative colitis and others [38-47].”
Background(2001) · PubMed · Cited by 266
Adrenal function in sepsis: The retrospective Corticus cohort study
Lipiner-Friedman, D., Sprung, C. L., Laterre, P. F., Weiss, Y., Goodman, S. V., Vogeser, M., Briegel, J., Keh, D., Singer, M., Moreno, R., et al. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000259465.92018.6e · Cited by 242
Strickland, I., Kisich, K., Hauk, P. J., Vottero, A., Chrousos, G. P., Klemm, D. J., & Leung, D. Y. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.585 · Cited by 215
de Castro, M., Elliot, S. J., Kino, T., Bamberger, C. M., Karl, M., Webster, E., & Chrousos, G. P. (1996) · Molecular Medicine · doi:10.1007/bf03401643 · Cited by 195 · cited 1×
“The most studied are GR alpha (GRa), the classical receptor that mediates GC actions, and GR beta (GRb), which can act as a dominant negative [34-37].”
Backgroundde Castro, M., Elliot, S. J., Kino, T., Bamberger, C. M., Karl, M., Webster, E., & Chrousos, G. P. (1996) · PubMed Central · Cited by 181
Ledderose, C., Möhnle, P., Limbeck, E., Schütz, S., Weis, F., Rink, J., Briegel, J., & Kreth, S. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825b8ebc · Cited by 130
Charmandari, E., Chrousos, G. P., Ichijo, T., Bhattacharyya, N., Vottero, A., Souvatzoglou, E., & Kino, T. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0112 · Cited by 130
Oppert, M., Reinicke, A., Gräf, K.-J., Barckow, D., Frei, U., & Eckardt, K.-U. (2000) · Intensive Care Medicine · doi:10.1007/s001340000685 · Cited by 106 · cited 1×
“The concentration of dexamethasone used in this assay is greater than the equivalent reported free plasma cortisol levels in septic shock patients treated with low-dose hydrocortisone therapy [56].”
BackgroundBeale, R. J., Janes, J., Brunkhorst, F. M., DOBB, G. J., Levy, M. M., Martin, G. S., Ramsay, G., Silva, E., Sprung, C. L., Vallet, B., et al. (2010) · Critical Care · doi:10.1186/cc9044 · Cited by 99 · cited 1×
“This contradictory evidence still leaves much uncertainty about the real benefits of GC therapy in sepsis [17-19].”
Backgroundfor the CORTICUS Study Group, Briegel, J., Sprung, C. L., Annane, D., Singer, M., Keh, D., Moreno, R., Möhnle, P., Weiss, Y., Avidan, A., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1627-9 · Cited by 93
Da, J., Chen, L., & Hedenstierna, G. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000250319.91575.bb · Cited by 91 · cited 1×
“Previous studies of the effect of sepsis on GR expression in humans and endotoxin-treated rats have shown apparently contradictory results in different cell types and tissues, leading the authors to suggest a cell-specific GR modulation of expression in sepsis [48-52].”
ResultCHIKANZA, I. C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04200.x · Cited by 87
Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsis
van den Akker, E. L. T., Koper, J. W., Joosten, K., de Jong, F. H., Hazelzet, J. A., Lamberts, S. W. J., & Hokken-Koelega, A. C. S. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1468-6 · Cited by 81 · cited 1×
“Previous studies of the effect of sepsis on GR expression in humans and endotoxin-treated rats have shown apparently contradictory results in different cell types and tissues, leading the authors to suggest a cell-specific GR modulation of expression in sepsis [48-52].”
ResultDARLINGTON, D. N., CHEW, G., HA, T., KEIL, L. C., & DALLMAN, M. F. (1990) · Endocrinology · doi:10.1210/endo-127-2-766 · Cited by 61 · cited 1×
“A protective role for glucocorticoid (GC) therapy in animal models of sepsis was shown many decades ago [6,7], leading to a proposal as early as 1940 for the use of GCs to treat patients with severe sepsis [8].”
BackgroundKoga, Y., Matsuzaki, A., Suminoe, A., Hattori, H., Kanemitsu, S., & Hara, T. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20308 · Cited by 58 · cited 1×
“A change in the expression of the GR isoforms with greater GRb expression has been proposed as a mechanism of GC resistance in chronic inflammatory conditions such as rheumatoid arthritis, ulcerative colitis and others [38-47].”
BackgroundGlucocorticoid Resistant Syndromes—Molecular Basis andClinical Presentations
Brönnegård, M., Stierna, P., & Marcus, C. (1996) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1996.04781.x · Cited by 55 · cited 2×
“Insufficient adrenal GC secretion and peripheral GC resistance are factors likely to influence the response of patients to corticosteroids [26-28].”
BackgroundPUJOLS, L., MULLOL, J., BENÍTEZ, P., TORREGO, A., XAUBET, A., HARO, J. D., & PICADO, C. (2003) · Respiratory Medicine · doi:10.1053/rmed.2002.1406 · Cited by 55 · cited 1×
“A change in the expression of the GR isoforms with greater GRb expression has been proposed as a mechanism of GC resistance in chronic inflammatory conditions such as rheumatoid arthritis, ulcerative colitis and others [38-47].”
BackgroundKamiyama, K., Matsuda, N., Yamamoto, S., Takano, K.-I., Takano, Y., Yamazaki, H., Kageyama, S.-I., Yokoo, H., Nagata, T., Hatakeyama, N., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00459.2007 · Cited by 53 · cited 1×
“Previous studies of the effect of sepsis on GR expression in humans and endotoxin-treated rats have shown apparently contradictory results in different cell types and tissues, leading the authors to suggest a cell-specific GR modulation of expression in sepsis [48-52].”
ResultTowers, R., Naftali, T., Gabay, G., Carlebach, M., Klein, A., & Novis, B. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02846.x · Cited by 52 · cited 2×
“A change in the expression of the GR isoforms with greater GRb expression has been proposed as a mechanism of GC resistance in chronic inflammatory conditions such as rheumatoid arthritis, ulcerative colitis and others [38-47].”
BackgroundGlucocorticoid receptor β in acute and chronic inflammatory conditions: Clinical implications
Goecke, A., & Guerrero, J. (2006) · Immunobiology · doi:10.1016/j.imbio.2005.11.002 · Cited by 51 · cited 1×
“A change in the expression of the GR isoforms with greater GRb expression has been proposed as a mechanism of GC resistance in chronic inflammatory conditions such as rheumatoid arthritis, ulcerative colitis and others [38-47].”
BackgroundSelf-citationCorticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli.
Hinshaw, L. B., Beller, B. K., Chang, A. C. K., Murray, C. K., Flournoy, D. J., Passey, R. B., & Archer, L. T. (1985) · PubMed · Cited by 50
Expression and binding activity of the glucocorticoid receptor are upregulated in septic muscle
Sun, X., Fischer, D. R., Pritts, T. A., Wray, C. J., & Hasselgren, P.-O. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00509.2001 · Cited by 42 · cited 4×
“However, some of the above studies have evaluated only the mRNA levels of the GR, which do not necessarily correlate with the receptor protein expression [47], while others have evaluated the GR protein expression using antibodies that do not discriminate between GRa and GRb or by GC binding assays, which evaluate onl…”
BackgroundResultInfluentialGoecke, I. A., Alvarez, C., Henríquez, J. P., Salas, K., Molina, M. L., Ferreira, A., & Gatica, H. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.07.303 · Cited by 42 · cited 3×
“However, some of the above studies have evaluated only the mRNA levels of the GR, which do not necessarily correlate with the receptor protein expression [47], while others have evaluated the GR protein expression using antibodies that do not discriminate between GRa and GRb or by GC binding assays, which evaluate onl…”
BackgroundMethodResultSelf-citationSUPRARENAL CORTICAL HORMONE AND SALT IN THE TREATMENT OF PNEUMONIA AND OTHER SEVERE INFECTIONS
Perla, D., & Marmorston, J. (1940) · Endocrinology · doi:10.1210/endo-27-3-367 · Cited by 42 · cited 1×
“A protective role for glucocorticoid (GC) therapy in animal models of sepsis was shown many decades ago [6,7], leading to a proposal as early as 1940 for the use of GCs to treat patients with severe sepsis [8].”
BackgroundGlucocorticoids in sepsis: dissecting facts from fiction
Marik, P. E. (2011) · Critical Care · doi:10.1186/cc10101 · Cited by 40 · cited 4×
“The role of GC therapy in septic patients is still controversial [19,53-55].”
BackgroundResultInfluentialControversies in the Treatment of Sepsis
Sandrock, C., & Albertson, T. E. (2010) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0029-1246290 · Cited by 37 · cited 2×
“The role of GC therapy in septic patients is still controversial [19,53-55].”
BackgroundExpression of human glucocorticoid receptor in lymphocytes of patients with autoimmune hepatitis
RAI, T., Ohira, H., Tojo, J., Abe, K., Yokokawa, J., Takiguchi, J., SHISHIDO, S., & Sato, Y. (2004) · Hepatology Research · doi:10.1016/j.hepres.2004.03.004 · Cited by 22 · cited 1×
“A change in the expression of the GR isoforms with greater GRb expression has been proposed as a mechanism of GC resistance in chronic inflammatory conditions such as rheumatoid arthritis, ulcerative colitis and others [38-47].”
BackgroundEvaluation of Glucocorticoid Sensitivity and Its Potential Clinical Applicability
Longui, C. A., & Faria, C. D. C. (2009) · Hormone Research in Paediatrics · doi:10.1159/000223413 · Cited by 19 · cited 2×
“Insufficient adrenal GC secretion and peripheral GC resistance are factors likely to influence the response of patients to corticosteroids [26-28].”
BackgroundDellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000298158.12101.41 · Cited by 9
The Glucocorticoid Receptor Protein: A Hormone-Dependent Transcription Factor
Carlstedt‐Duke, J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/154.2_pt_2.s7 · Cited by 4
Cited by
Annane, D., Pastores, S. M., Arlt, W., Balk, R. A., Beishuizen, A., Briegel, J., Carcillo, J., Christ-Crain, M., Cooper, M. S., Marik, P. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4914-x · Cited by 220
“Sepsis is also characterized by an increased expression of the GR isoform GR-β in circulating cells, resulting in an imbalance between GRα and GRβ [80, 83].”
Backgroundde Jong, M. F., Molenaar, N., Beishuizen, A., & Groeneveld, A. J. (2015) · Critical Care · doi:10.1186/s13054-014-0721-8 · Cited by 150
“Finally, we did not know or evaluate the potentially interfering phenomenon of steroid resistance in critical illness [30].”
BackgroundAdrenal function and dysfunction in critically ill patients
Téblick, A., Peeters, B., Langouche, L., & den Berghe, G. V. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0185-7 · Cited by 173
The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Lockett, J., Inder, W. J., & Clifton, V. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae008 · Cited by 135
Glucocorticoids in Sepsis: To Be or Not to Be
Vandewalle, J., & Libert, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01318 · Cited by 132
Metadata
- Authors
- Guerrero, J., Gatica, H. A., Rodríguez, M., Estay, R., & Goecke, I. A.
- Affiliations
- University of Chile (CL)
- Corresponding author
- Goecke, Irmgadt Annelise
- Venue
- Critical Care
- Published
- 2013-06-12
- Volume
- 17
- Issue
- 3
- Pages
- R107-R107
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC4056039
- OpenAlex
- W2069200792
- Cited by
- 71
- References
- 58
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 8 · 2016: 3 · 2015: 5 · 2014: 6 · 2013: 2
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- sepsis, septic shock, glucocorticoid resistance, glucocorticoid receptor beta, glucocorticoid receptor alpha, peripheral blood mononuclear cells, glucocorticoid sensitivity, T cells, B cells, glucocorticoid therapy
- MeSH terms
- Adult, Aged, Drug Resistance, Female, Gene Expression Regulation, Glucocorticoids, Humans, Male, Middle Aged, Prospective Studies, Receptors, Glucocorticoid, Cohort Studies, Sepsis, K562 Cells, Protein Isoforms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.